0
0 (0%)
Immune Therapeutics, Inc. [IMUN]
Source:
Company Overview
Immune Therapeutics, Inc is a developer and marketer of pharmaceutical, biotechnology, and MedTech products that have a well-defined path to market.
| Country | United States |
| Headquarters | winter park, florida |
| Phone Number | (888) 613-8802 |
| Industry | manufacturing |
| CEO | Noreen Griffin |
| Website | www.biostaxcorp.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | |
| Operating Profit | $-0.1 |
| Net Income | $-0 |
| Net Cash | $-0 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -177.5% |
| Profit as % of Stockholder Equity |
Management Effectiveness
| Return on Equity | |
| Return on Assets | -658.1% |
| Turnover Ratio | |
| EBITA | $-0.1 |
Balance Sheet and Cash Flow Measures
| Total Assets | $0 |
| Total Liabilities | $5.3 |
| Operating Cash Flow | $-0 |
| Investing Cash Flow | |
| Financing Cash Flow | $0 |
